Professional Documents
Culture Documents
ORIGINAL ARTICLE
KEYWORDS Abstract Background: Endoscopic sinus surgery (ESS) has become the treatment of choice for
Endoscopic sinus surgery; nasal polyposis and chronic rhinosinusitis that cannot be adequately managed with medical
Nasal packing; therapy. Nasal packing is usually placed after ESS to prevent synechiae formation and postopera-
Synechiae; tive bleeding and to support wound healing.
Granulation Objectives: This study was done to evaluate the effect of different materials on the formation of
synechiae and excessive granulation tissue in the middle meatus in patients who had undergone
ESS.
Methods: A total of 90 patients who had undergone ESS were studied prospectively. At the end of
ESS each patient was packed with one of the three different materials randomly. The outcome var-
iable was the formation of synechiae and excessive granulation tissue in the middle meatus, which
was identied from endoscopic evaluations performed 34 weeks and 1012 weeks after surgery.
Results: We observed signicant intergroup differences in the effect on the formation of synechiae
in the middle meatus. The nasopore group was superior to the other two groups and there is a sig-
nicant reduction in synechiae formation in the nasopore group than both other groups.
Conclusion: Among patients who had undergone ESS for rhinosinusitis with or without polyps,
the incidence of synechiae and excessive granulation tissue in the middle meatus in the patients who
received nasopore packing was less to that of synechiae in the patients who received merocel and
mitomycin C.
2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Ear, Nose, Throat and
Allied Sciences.
1. Introduction
2090-0740 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Ear, Nose, Throat and Allied Sciences.
http://dx.doi.org/10.1016/j.ejenta.2013.12.001
24 T. Mohammed
Numerous techniques including suture medialization, partial tion, anterior nasal discharge and posterior nasal discharge.
resection of the middle turbinate, and nasal packing in the Objective assessment of all patients was performed. Crusts, un-
middle meatus, have been used to prevent postoperative healthy mucosa, excessive granulation tissue and synechiae in
synechiae formation.2 Nasal packing remains the most com- the middle meatus were identied from the medical records of
mon procedure to prevent synechiae formation. Conventional the endoscopic evaluations performed 34 weeks and 10
packing products, such as vaseline gauze strip and expandable 12 weeks after surgery. Granulation tissue formation is common
polyvinyl acetate (Merocel) are non-absorbable materials. during the mucosal healing process; therefore, we considered
New biodegradable packing materials with various degrees only those cases that showed excessive granulation tissue involv-
of efcacy have also been developed, for example, Floseal, ing more than 10% of the middle meatus.5
MeroGel/Meropak, Nasopore (Polyganics, The Netherlands); Statistical analysis of the data obtained in this study was
and carboxymethylcellulose.3 performed. Comparisons of all the parameters, including the
outcome variables for the formation of synechiae and excessive
2. Objectives granulation tissue in the middle meatus for the packing
material groups were performed.
The aim of this study was done to evaluate the effect of three
different materials [Mitomycin c, Merocel, and Nasopore 4. Results
(Polyganics)] on the formation of synechiae and excessive
granulation tissue in the middle meatus in patients who had A total of 90 patient were included in this study 6 were lost
undergone ESS. during follow up and were replaced, they were 35 female
(39%) and 55 male (61%) ranging in age from 19 to 49 years
3. Patients and methods with mean of 35 y, median 36 y and Standard Deviation 9.
with bilateral chronic rhinosinusitis with or without sinonasal
polyposis. Functional endoscopic sinus surgery had been done
This study was held at Benha University hospitals, in the per-
for all patients (see Table 1).
iod from January 2012 to March 2013. The ethical committee
of Benha Medical School approved the study and informed
consents signed by all patients were taken. The study was con- Table 1 Sex distribution in the study.
ducted on 90 patients who had undergone ESS. 6 patients were Sex No %
lost during the follow up and were replaced. All patients were Male 55 61
divided into three groups as; 30 packed with Nasopore, 30 with Female 35 39
MMC and the last 30 with Merocel. The Lund-Mackay com- Total 90 100.0
puted tomography (CT) staging system (0/1/2, per side) was
used to assess the ndings of the preoperative CT, and that
The presenting clinical symptoms in patients of our study
of endoscopic evaluations for the nasal polyp grading system
are bilateral nasal obstruction which presented in 67 patients
(0; no visible polyps, 1; polyps conned to the middle meatus,
(74.4%), anterior nasal discharge presented in 32 patients
2; polyps that had grown beyond the middle meatus but were
(35.5%), posterior nasal discharge presented in 27 patients
not completely obstructing the nasal cavity, 3; polyps com-
(30), headache presented in 63 patients (70%) and facial pain
pletely obstructing the nasal cavity).4
presented in 16 patients (17.7) (see Fig. 1, Table 2).
Patient exclusion criteria include patients with concha bul-
osa, history of sino-nasal trauma, previous sino-nasal surgery,
patients with unilateral sinusitis such as maxillary sinusitis of
dental origin, patients whom had underlying systemic disease
such as; cystic brosis, immune deciency and ciliary move-
ment disorder, patients with chronic specic inammatory dis-
ease such as rhinoscleroma, T.B, syphilis, history of bleeding
disorders and patients with complicated sinusitis.
All patients were admitted to our department to undergo
ESS, and at the end of the surgery, the chosen packing material
was impregnated with antibiotics and introduced in the middle
meatus. The merocel packs were removed 48 hours after
surgery. In contrast, nasopore was left in place, if remnants were
found it was suctioned out during the patients follow-up visit Figure 1 Clinical presenting symptoms.
(5:10 days after discharge). While in the MMC group a piece
of cotton soaked in 1 ml of MMC in a concentration of Table 2 Clinical presenting symptoms in patients of our
0.5 mg/ml was placed in the middle meatus. After a period of study.
5 minutes, the cotton pieces were removed and the nasal cavity
Symptoms No (90) %
was irrigated with 30 ml of sterile normal saline. The postoper-
ative regimens for all patients were quite similar, including 2- Nasal obstruction 67 74.4
Anterior nasal discharge 32 35.5
weeks oral antibiotic therapy along with the administration of
Posterior nasal discharge 27 30
a topical nasal steroid, isotonic saline irrigation and regular fol-
Headache 63 70
low-up examinations. Subjective evaluation for all patients was Facial pain 16 17.7
carried out 12 weeks postoperatively including; nasal obstruc-
The role of different materials for prevention of synechiae following endoscopic sinus surgery 25
Objective endoscopic assessment of the patients 3 months Unhealthy mucosa presented in 5 patients (16.7%) of the
after ESS: the granulations presented in 5 patients (16.7) of nasopore group, 6 patients (20.0%) of the MMC group and
the nasopore group, 8 patients (26.7%) of the MMC group 7 patients (23.3%) of the Merocel group.
and 10 patients (33.3%) of the Merocel group. The crusts presented in 5 patients (16.7%) of the nasopore
The synechiae presented in 3 patients (10%) of the group, 6 patients (20.0%) of the MMC group and 7 patients
nasopore group, 8 patients (26.7%) of the MMC group and (23.3%) of the Merocel group (see Table 6, Figs. 613).
10 patients (33.3%) of the Merocel group.
Table 6 Objective evaluation by endoscopy three months after ESS.
Findings Nasopore MMC Merocel Total
No = 30 % No = 30 % No = 30 % No = 90 %
Granulations +VE 5 16.7 8 26.7 10 33.3 21 23.3
VE 25 83.3 22 73.3 20 66.7 69 76.7
Synechiae +VE 3 10 8 26.7 10 33.3 21 23.3
VE 27 90 22 73.3 20 66.7 69 76.7
Unhealthy mucosa +VE 5 16.7 6 20.0 7 23.3 18 20
VE 25 83.3 24 80.0 23 76.7 72 80
Crusts +VE 5 16.7 6 20.0 7 23.3 18 20
VE 25 83.3 24 80.0 23 76.7 72 80
MM L
L
T
Figure 10 Endoscopic assessment of the granulations 3 month Figure 12 Endoscopic assessment for unhealthy mucosa
after FESS. 3 month after FESS.
Figure 11 Endoscopic assessment of the synechiae 3 month after Figure 13 Endoscopic assessment for the crusts 3 month after
FESS. ESS.